55. MicuRX Pharmaceuticals Inc
Headquarters: Hayward, California
Bought By: Delian Capital and BVCF
Headquarters: Beijing, China
Pharmaceuticals company MicuRX are constantly looking to make advancements in the field, but it’s a very expensive business. In 2017, they struck a deal with Delian Capital and BCVF and their affiliates for over 100 million yen to fund ongoing research for oral antibiotics. This partnership also helped them secure a Chinese NDA filing.
“We are thrilled to meet the high expectations for clinical performance of contezolid acefosamil. With this additional funding provided by our long-standing investors and their affiliates, we are quickly advancing our clinical development programs both in the USA and China,” stated Zhengyu Yuan, Ph.D., the CEO.